PATENT CLAIM ANALYSIS

Application Number: 15771036
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "001400"]

Abstract:
Embodiments of the present disclosure provide polypeptides, related materials and compositions, and methods for their use. In certain embodiments, the present disclosure provides a monomeric Tamm-Horsfall Protein polypeptide, or a biologically active truncation thereof. Other embodiments provide polynucleotides encoding a polypeptide described herein, nucleic acid expression vectors including the polynucleotides, and recombinant host cells including the expression vector. Yet other embodiments provide pharmaceutical compositions including a polypeptide described herein. Also provided are methods for treating a renal disease, disorder, or condition in a subject and/or modulating an immune response in a subject.

Claim (Index 22):
The pharmaceutical composition of  claim 21 , wherein the purified or isolated truncated THP polypeptide comprises an amino acid sequence at least 85% identical to an amino acid sequence chosen from SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 91.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15026574', '13639002', '15147848', '13278131', '14414734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7935329300903428
- 35 USC 102 Novelty (BERT): 0.5235604549052899
- Combined Prediction Score: 0.7665356825718375
- Mean Citation Score: 293.4831920000001
- Max Citation Score: 317.2552
- Similarity Product: 208.8155843096256

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test